Zacks Research Issues Pessimistic Outlook for CLB Earnings

Core Laboratories Inc. (NYSE:CLB - Free Report) - Stock analysts at Zacks Research reduced their Q4 2026 EPS estimates for Core Laboratories in a research note issued on Wednesday, May 14th. Zacks Research analyst R. Department now forecasts that the oil and gas company will earn $0.28 per share for the quarter, down from their prior forecast of $0.34. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share.

CLB has been the subject of a number of other research reports. Stifel Nicolaus dropped their price target on Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a research report on Tuesday, April 15th. Wall Street Zen cut Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Finally, Citigroup dropped their price target on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research report on Tuesday, May 13th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $15.00.

Core Laboratories Price Performance

NYSE:CLB traded down $0.05 during trading hours on Monday, hitting $10.88. The company's stock had a trading volume of 434,650 shares, compared to its average volume of 405,683. The business's 50-day moving average is $12.62 and its two-hundred day moving average is $16.17. The company has a market capitalization of $509.85 million, a PE ratio of 16.48, a PEG ratio of 0.99 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. Core Laboratories has a 52-week low of $10.14 and a 52-week high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The business had revenue of $123.59 million during the quarter, compared to analyst estimates of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The business's revenue for the quarter was down 4.7% compared to the same quarter last year. During the same period last year, the company earned $0.19 earnings per share.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th will be paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Monday, May 5th. Core Laboratories's payout ratio is 6.78%.

Institutional Trading of Core Laboratories

A number of hedge funds have recently added to or reduced their stakes in CLB. Assetmark Inc. acquired a new stake in Core Laboratories during the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC increased its position in Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock worth $35,000 after purchasing an additional 1,293 shares in the last quarter. Nisa Investment Advisors LLC increased its position in Core Laboratories by 2,688.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock worth $42,000 after purchasing an additional 2,339 shares in the last quarter. AlphaQuest LLC increased its position in Core Laboratories by 265,800.0% during the 1st quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company's stock worth $40,000 after purchasing an additional 2,658 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock worth $57,000 after purchasing an additional 2,936 shares in the last quarter. 97.81% of the stock is owned by institutional investors and hedge funds.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.